Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On International Clinical Trials Day this year, Professor Lamb will be giving a free public talk entitled: "Clinical Trials: One of the most important medical inventions in the last 100 years".

Professor Sallie Lamb, Co-Director of the Oxford Clinical Trials Research Unit at the University of Oxford will talk about the history of clinical trials, and explain important concepts such as randomisation, masking and minimisation of bias. Professor Lamb will describe how trials have progressed the management of nearly all medical conditions, and what challenges remain. She will discuss the range of ethical dilemmas raised by clinical trials, and the difficulties of operationalising large experiments involving many hundreds and sometimes thousands of people. Questions and discussion will be welcome.

 

Click on this link to find out more http://oxfordbrc.nihr.ac.uk/event/clinical-trials-one-of-the-most-important-medical-inventions-in-the-last-100-years/

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.